Regenecare® in the Treatment of Skin Rash Associated With Cetuximab (Erbitux®) or Other EGFR Treated Cancer Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00498992

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:35:26.514471+00:00

Published At

2013-09-20T00:00:00+00:00

Record Updated At

2013-09-20

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Dermatologic Complications", "Unspecified Adult Solid Tumor, Protocol Specific"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2013-09-20"

protocolSection.identificationModule.nctId

"NCT00498992"

protocolSection.identificationModule.officialTitle

"Regenecare\u00ae in the Treatment of Skin Rash Associated With Cetuximab (Erbitux\u00ae) or Other EGFR Treated Cancer Patients"

protocolSection.statusModule.overallStatus

"UNKNOWN"

protocolSection.designModule.phases

["NA"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Dermatologic Complications (protocolSection.conditionsModule.conditions)
• Unspecified Adult Solid Tumor, Protocol Specific (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.